3 promoters of pharma firm among 8 booked by CBI
Tribune News Service
Chandigarh, July 13
The Central Bureau of Investigation (CBI) has booked three promoters-cum-directors, three former directors and two employees of a Chandigarh-based private pharmaceutical company and other yet-to-be-identified public servants and private employees in connection with an alleged Rs 33.79-crore fraud with the State Bank of India (SBI).
The premier investigation agency has registered the case on a complaint of the State Bank of India, Chandigarh, under Sections 120-B read with Sections 420, 467, 468 and 471 of IPC and Section 13 (2) read with Section 13 (1) (c) (d) of the Prevention of Corruption Act, 1988, in this connection, an official spokesperson said here today.
According to CBI sources, those named in the FIR include Suyog Jain, Vivek Gupta and RS Gujaral (all promoters-cum-directors of M/s Vardhaman Life Sciences Pvt Ltd), SK Singla, Ravinder Goel and Pramod Jain (all former directors of M/s Vardhaman Life Sciences Pvt Ltd) and Sandeep Agarwal and Akshat Rana (both employees of the private firm). However, no arrests have been made so far.
It was alleged in the complaint that the accused persons, in connivance and criminal conspiracy with bank branch officials, siphoned off bank funds by misrepresentation, fabrication and forgery of documents and falsification of financial records. In this process, an alleged loss of Rs 33.79 crore was caused to the bank, the complaint read.
Following the registration of the FIR, searches were being conducted at eight locations in Chandigarh, Delhi and Cuddalore (Tamil Nadu) on the premises of the accused persons, which led to the recovery of incriminating documents, the CBI spokesperson said, adding that “investigation was under way”.
